Nurix Therapeutics (NRIX) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $101.8 million.
- Nurix Therapeutics' Shares Outstanding rose 3418.55% to $101.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $101.8 million, marking a year-over-year increase of 3418.55%. This contributed to the annual value of $101.8 million for FY2025, which is 3418.55% up from last year.
- Nurix Therapeutics' Shares Outstanding amounted to $101.8 million in Q4 2025, which was up 3418.55% from $76.9 million recorded in Q3 2025.
- In the past 5 years, Nurix Therapeutics' Shares Outstanding ranged from a high of $101.8 million in Q4 2025 and a low of $39.1 million during Q1 2021
- Moreover, its 5-year median value for Shares Outstanding was $48.1 million (2023), whereas its average is $56.9 million.
- In the last 5 years, Nurix Therapeutics' Shares Outstanding skyrocketed by 107074.96% in 2021 and then soared by 143.35% in 2022.
- Nurix Therapeutics' Shares Outstanding (Quarter) stood at $44.7 million in 2021, then increased by 5.62% to $47.2 million in 2022, then rose by 3.28% to $48.7 million in 2023, then soared by 55.73% to $75.9 million in 2024, then soared by 34.19% to $101.8 million in 2025.
- Its Shares Outstanding stands at $101.8 million for Q4 2025, versus $76.9 million for Q3 2025 and $76.4 million for Q2 2025.